Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Erstveröffentlichung
2020Authors
Zucca, E.
Arcaini, L.
Buske, Christian
Johnson, P. W.
Ponzoni, M.
Wissenschaftlicher Artikel
Published in
Annals of oncology ; 31 (2020), 1. - S. 17-29. - ISSN 0923-7534. - eISSN 1569-8041
Link to publication
https://dx.doi.org/10.1016/j.annonc.2019.10.010Institutions
UKU. Comprehensive Cancer Center Ulm (CCCU)Subject headings
[Free subject headings]: marginal zone B-cell lymphoma (MZL) | extranodal marginal zone lymphoma (EMZL) | splenic marginal zone lymphoma (SMZL) | nodal marginal zone lymphoma (NMZL) | mucosa-associated lymphoid tissue (MALT) | clinical practice guidelines | B-CELL LYMPHOMA | GASTRIC MALT LYMPHOMA | HELICOBACTER-PYLORI ERADICATION | RITUXIMAB MONOTHERAPY | TISSUE LYMPHOMA | RISK STRATIFICATION | RADIATION-THERAPY | MULTICENTER | PHASE-2 | RADIOTHERAPY[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item recordThis could also interest you:
-
Rituximab biosimilars for lymphoma in Europe
Jurczak, Wojciech; Danecka, Monika Dlugosz; Buske, Christian (2019)Wissenschaftlicher Artikel
-
Indolent lymphoma. Therapy strategies
Viardot, Andreas; Herfarth, Klaus; Dreyling, Martin (2015)Wissenschaftlicher Artikel
-
Molecular aspects of B-cell lymphomas of the gastrointestinal tract
Barth, Thomas F. E. et al. (2001)Wissenschaftlicher Artikel